Dishman Pharmaceuticals and Chemicals - wholly owned subsidiary company - Carbogen Amcis AG., Switzerland has acquired Creapharm Parenterals, a subsidiary of France based Greapharm Group.
Creapharm Parenterals is a contract development and manufacturing organization specializing in liquid, semi-solid and injectable aseptic dosage forms. As part of this acquisition, Creapharm Parenterals has changed its name to ‘CARBOGEN AMCIS SAS’.
The acquisition will extend ‘CARBOGEN AMCIS' comprehensive range of development and manufacturing services by adding complementary formulation, lyophilization services and sterile GMP capabilities for the fast supply of drug products, including highly potents, for preclinical studies and clinical trials (Phase I, II & III).
Dishman Pharmaceuticals and Chemicals is engaged in manufacturing of Bulk API, Intermediates, Specialties and Quats. The company has started production of a range of phase transfer catalysts and quaternary ammonium and phosphonium compounds in 1989.
